Skip to content

Zhiqiang Zhou

3 papers in the library · 71 citations · publishing 2012-2026

Papers

Sort Most recent Most cited

Prophylactic esketamine to reduce postpartum depression in primiparae: A multicentre, double-blind, randomised clinical trial.

European journal of anaesthesiology January 29, 2026 Tiantian Chu, Xiaoling Peng, Keliang Wan et al. 2 citations

Postpartum depression (PPD) is a common complication after childbirth, especially in primiparae. This trial sought to evaluate whether prophylactic administration of esketamine during the perinatal period could prevent PPD in primiparae without predisposition to prenatal depression. A prospective, double-blind, multicentre, randomised controlled trial. Three academic hospitals. Primiparae...

Alterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine

Scientific Reports June 5, 2017 Ze-Min Xie, Xingming Wang, Ning Xu et al. 69 citations

Although pain is frequently accompanied with depression, little is known about the risk factors contributing to individual differences to the comorbidity of pain and depression. In this study, we examined whether cytokines and brain-derived neurotrophic factor (BDNF) might contribute to the individual differences in the development of neuropathic pain-induced depression. Rats were randomly...

Role of L-arginine/nitric oxide pathway in the antidepressant effects of ketamine

Zhonghua xingwei yixue yu naokexue zazhi September 20, 2012 Guang-Fen Zhang, Nan Wang, Jinyun Shi et al.

Objective To study the role of L-arginine/nitric oxide (NO) pathway in the antidepressant effects of ketamine. Methods Forty two male Wistar rats (200-250 g) were equally randomized into 7 groups (n=6): control group (C group), L-Arginine (a precursor of NO) group (LA group), L-NAME(an non-selectivity inhibitor of NO synthase) group (LN group), ketamine 3 mg/kg group (K3 group), ketamine 10...